Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2018 | 1 |
2019 | 1 |
2020 | 1 |
2021 | 2 |
2022 | 1 |
2023 | 2 |
2024 | 1 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Inhibition of G Protein-Coupled Receptor Kinase 2 Promotes Unbiased Downregulation of IGF1 Receptor and Restrains Malignant Cell Growth.
Cancer Res. 2021 Jan 15;81(2):501-514. doi: 10.1158/0008-5472.CAN-20-1662. Epub 2020 Nov 6.
Cancer Res. 2021.
PMID: 33158816
Competing Engagement of β-arrestin Isoforms Balances IGF1R/p53 Signaling and Controls Melanoma Cell Chemotherapeutic Responsiveness.
Cismas S, Pasca S, Crudden C, Trocoli Drakensjo I, Suleymanova N, Zhang S, Gebhard B, Song D, Neo S, Shibano T, Smith TJ, Calin GA, Girnita A, Girnita L.
Cismas S, et al.
Mol Cancer Res. 2023 Dec 1;21(12):1288-1302. doi: 10.1158/1541-7786.MCR-22-0871.
Mol Cancer Res. 2023.
PMID: 37584671
Item in Clipboard
Below the Surface: IGF-1R Therapeutic Targeting and Its Endocytic Journey.
Crudden C, Song D, Cismas S, Trocmé E, Pasca S, Calin GA, Girnita A, Girnita L.
Crudden C, et al. Among authors: cismas s.
Cells. 2019 Oct 9;8(10):1223. doi: 10.3390/cells8101223.
Cells. 2019.
PMID: 31600876
Free PMC article.
Review.
Item in Clipboard
Natural killer cells drive 4-1BBL positive uveal melanoma towards EMT and metastatic disease.
Neo SY, Oliveira MMS, Tong L, Chen Y, Chen Z, Cismas S, Burduli N, Malmerfelt A, Teo JKH, Lam KP, Alici E, Girnita L, Wagner AK, Westerberg LS, Lundqvist A.
Neo SY, et al. Among authors: cismas s.
J Exp Clin Cancer Res. 2024 Jan 9;43(1):13. doi: 10.1186/s13046-023-02917-5.
J Exp Clin Cancer Res. 2024.
PMID: 38191418
Free PMC article.
Item in Clipboard
Minimal residual disease in chronic lymphocytic leukemia: A consensus paper that presents the clinical impact of the presently available laboratory approaches.
Tomuleasa C, Selicean C, Cismas S, Jurj A, Marian M, Dima D, Pasca S, Petrushev B, Moisoiu V, Micu WT, Vischer A, Arifeen K, Selicean S, Zdrenghea M, Bumbea H, Tanase A, Grewal R, Pop L, Aanei C, Berindan-Neagoe I.
Tomuleasa C, et al. Among authors: cismas s.
Crit Rev Clin Lab Sci. 2018 Aug;55(5):329-345. doi: 10.1080/10408363.2018.1463508. Epub 2018 May 25.
Crit Rev Clin Lab Sci. 2018.
PMID: 29801428
Review.
Item in Clipboard
IGF-1R is a molecular determinant for response to p53 reactivation therapy in conjunctival melanoma.
Song D, Cismas S, Crudden C, Trocme E, Worrall C, Suleymanova N, Lin T, Zheng H, Seregard S, Girnita A, Girnita L.
Song D, et al. Among authors: cismas s.
Oncogene. 2022 Jan;41(4):600-611. doi: 10.1038/s41388-021-02111-x. Epub 2021 Nov 17.
Oncogene. 2022.
PMID: 34785779
Item in Clipboard
Correction: IGF-1R is a molecular determinant for response to p53 reactivation therapy in conjunctival melanoma.
Song D, Cismas S, Crudden C, Trocme E, Worrall C, Suleymanova N, Lin T, Zheng H, Seregard S, Girnita A, Girnita L.
Song D, et al. Among authors: cismas s.
Oncogene. 2023 Mar;42(11):858. doi: 10.1038/s41388-023-02607-8.
Oncogene. 2023.
PMID: 36759575
No abstract available.
Item in Clipboard
Cite
Cite